← FDA DRUG APPROVALS

FDA ANDA · ANDA218442

OXCARBAZEPINE

Sponsor: BIOCON PHARMA LTD

APPLICATION
ANDA218442
TYPE
ANDA
ROUTE
EXTENDED RELEASE
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)

Products

OXCARBAZEPINENone (Tentative Approval)
OXCARBAZEPINE 300MG · TABLET · EXTENDED RELEASE
OXCARBAZEPINENone (Tentative Approval)
OXCARBAZEPINE 600MG · TABLET · EXTENDED RELEASE

Approval history

2025-01-08UNKNOWN · Original · standardTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →